期刊档案 · OBSTETRICS & GYNECOLOGY
Indian Journal of Gynecologic Oncology
ISSN 2363-8397 · eISSN 2363-8400 · Springer Nature
Indian Journal of Gynecologic Oncology 中科院 医学 4区（2025 年升级版），影响因子 0.3（官网公布），订阅期刊，APC 约 2,990 美元，近 24 个月 89 篇文章投稿到接收中位 119 天，2025 年发文 136 篇，ESCI、Scopus 收录。
研究范围
研究范围与定位
Indian Journal of Gynecologic Oncology 由 Springer Nature 出版，属中科院医学大类（2025 升级版4区）。按 OpenAlex 近年发文统计，该刊主要发表 Ovarian cancer diagnosis and treatment、Endometrial and Cervical Cancer Treatments、Cervical Cancer and HPV Research 等主题的论文，这 3 个主题约占 48.2%。（根据 OpenAlex 主题统计与中科院分区数据生成）
The Indian Journal of Gynecologic Oncology (IJGO) is an academic initiative of the Association of Gynecological Oncologists of India (AGOI). One of the primary objectives of AGOI is to provide a platform for gynecological oncologists from India and other countries to exchange ideas, propagate the advancement of science in this field. AGOI was established in 1991 and is the only association in India dedicated to the specialty of gynecologic oncology. It is a registered body and is recognized by the International Gynecological Cancer Society (IGCS).IJGO is a double-blind, double peer-reviewed journal that features articles written by clinicians, clinical researchers and basic scientists about research and patient care issues in gynecological oncology and breast cancer. This journal focuses on new and emerging technologies, cutting-edge science, advances, preventive and therapeutic aspects of gynecological oncology.The Journal aims to continue its mission of being the ambassador of gynecological oncology research and innovations from India, and also serve as a platform of gynecological oncologists from across the world to share their research findings.
摘自期刊官网 Aims & Scope
研究方向（LetPub）：OBSTETRICS & GYNECOLOGY
主编 S. P. Somashekhar出版商官网
编委会国家分布：未见中国大陆编委；主要国家 印度 38、美国 6、英国 2、孟加拉国 1（共 47 位编委标注了国家） 编委会 ↗出版商官网 ·
主要研究主题 OpenAlex 近年发文统计，占比为近似值
- Ovarian cancer diagnosis and treatmentMedicine19.5%
- Endometrial and Cervical Cancer TreatmentsMedicine16.9%
- Cervical Cancer and HPV ResearchMedicine11.8%
- Uterine Myomas and TreatmentsMedicine7.3%
- Intraperitoneal and Appendiceal MalignanciesMedicine5.2%
- Endometriosis Research and TreatmentMedicine3.8%
- Global Cancer Incidence and ScreeningMedicine3.7%
- Sarcoma Diagnosis and TreatmentMedicine3%
分区与收录
学科分区与数据库收录
中科院期刊分区表
期刊分区表（ 2025年3月升级版）医学 4 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 4 区 |
| 小类 | 妇产科学OBSTETRICS & GYNECOLOGY | 4 区 |
Top 期刊：否综述期刊：否
《新锐期刊分区表》（ 2026年3月发布）医学 4 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 4 区 |
| 小类 | 妇产科学OBSTETRICS & GYNECOLOGY | 4 区 |
Top 期刊：否综述期刊：未标注
期刊分区表（ 2023年12月旧的升级版）未收录
该期刊未被此版本分区表收录。
数据库收录
ESCIScopusLetPub
国际期刊预警名单：各版本均未列入LetPub
期刊官网自述收录
Embase出版商官网
其他：Google Scholar、EBSCO、ProQuest、Dimensions、CNKI、Baidu、Naver、OCLC、Portico、CLOCKSS、Semantic Scholar
期刊官网列出的收录清单，未与各数据库逐一核对；Web of Science 各子库以上方记录为准。
不同版本、大类与小类分别展示，不将不同评价口径合并为一个分区值；投稿与考核前请确认所在机构采用的版本。
指标
影响力指标与发文规模
影响力指标
- 影响因子（出版商公布） 2025
- 0.3出版商官网 ·
- 五年影响因子（出版商公布） 2025
- 0.4出版商官网 ·
- CiteScore 2026-06
- 0.7LetPub ·
- SJR 2026-06
- 0.17LetPub ·
- SNIP 2026-06
- 0.26LetPub ·
- h-index
- 13OpenAlex ·
- i10-index
- 22OpenAlex ·
- 两年平均被引
- 0.47OpenAlex ·
- 自引率
- 0%LetPub ·
- Gold OA 文章占比
- 4.88%LetPub ·
发文规模
- 年文章数
- 133LetPub ·
- 年下载量（出版商公布） 2025
- 56,700出版商官网 ·
逐年发文量 OpenAlex 统计 · 累计 1,099 篇 · 当年数据不完整
| 年份 | 发文量 | 其中 OA | 被引 |
|---|---|---|---|
| 2026 | 57 | 4 | 4 |
| 2025 | 136 | 12 | 60 |
| 2024 | 169 | 9 | 107 |
| 2023 | 73 | 4 | 91 |
| 2022 | 85 | 5 | 178 |
| 2021 | 105 | 12 | 371 |
不同来源的统计口径与观测时间不同，页面保留各来源原值；“出版商公布”为期刊官网自述数据。
审稿与录用
审稿周期与录用情况
文章统计的审稿周期 Crossref 登记的稿件日期 · 至
119 天投稿到接收中位数 · P25–P75 86 天 – 166 天
- 接收到上线
- 中位数 18 天（89 篇）
- 投稿到上线
- 中位数 138 天
- 样本
- 89 篇有投稿与接收日期的文章（窗口内共 247 篇），最近一篇接收于
只统计最终被录用并发表的文章，不含被拒稿件的处理时间，因此通常长于出版商公布的"首次决定时间"。
其他来源
- 投稿到首次决定
- 22 天出版商官网 ·
- 评审方式
- 双盲同行评审出版商官网
社区反馈来自投稿者样本，置信度 0.5，不代表期刊承诺；“出版商公布”的时间节点定义以官网为准。
费用与开放获取
版面费与开放获取政策
订阅期刊LetPub
订阅期刊，文章需订阅或购买阅读，通常不收取版面费。
| 来源 | 文章处理费 | 费用减免 | 许可证 | 观测时间 |
|---|---|---|---|---|
| OpenAlex | USD 2,990 / EUR 4,790 | — | — |
费用以期刊官网为准；不同来源的观测时间可能不同，页面保留各来源原值，不做平均。
投稿要求
文章类型与投稿政策（官网）
投稿准备要点5 项，摘自作者指南
- 摘要
- 150–250 词
- 关键词
- ≥ 4 个
- 正文篇幅
- ≤ 3,000 词
- 参考文献格式
- 顺序编码制（按引用顺序编号）
- 推荐审稿人
- 可选
接收的文章类型12 种，含篇幅限制
- case reportEditorial – word limit 1500 words Original Articles – word limit 3000 (excluding references), 40references maximum, no more than 5 figures/tables. Review Articl…未说明篇幅
- case reportsCase Reports - word limit 1500 (excluding references), 10references; however should not be exhaustive no more than 3 figures/tables.未说明篇幅
- editorialEditorial – word limit 1500 words Original Articles – word limit 3000 (excluding references), 40references maximum, no more than 5 figures/tables. Review Articl…正文 ≤ 1,500 词
- images in breast oncologyImages in Breast oncology未说明篇幅
- images in gyne – oncologyImages in Gyne – oncology未说明篇幅
- instrumentation and techniqueInstrumentation and Technique - word limit 1500 (excluding references), 10references; however should not be exhaustive no more than 2 figures/tables.未说明篇幅
- letterEditorial – word limit 1500 words Original Articles – word limit 3000 (excluding references), 40references maximum, no more than 5 figures/tables. Review Articl…未说明篇幅
- letter to editorLetter to Editor - word limit 750 (excluding references), 10references; however should not be exhaustive no more than 1 figure/table.未说明篇幅
- original articleEditorial – word limit 1500 words Original Articles – word limit 3000 (excluding references), 40references maximum, no more than 5 figures/tables. Review Articl…未说明篇幅
- original articlesOriginal Articles – word limit 3000 (excluding references), 40references maximum, no more than 5 figures/tables.未说明篇幅
- review articleEditorial – word limit 1500 words Original Articles – word limit 3000 (excluding references), 40references maximum, no more than 5 figures/tables. Review Articl…未说明篇幅
- review articlesReview Articles – word limit 3000 (excluding references), 40references; however should not be exhaustive no more than 5 figures/tables.未说明篇幅
官网政策摘录AI 使用、作者资格、利益冲突、数据可用性、出版伦理、许可与版权、开放获取、同行评审、试验注册 / 报告规范
- AI 使用 Generative AI Images
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein. Back to top
原文 ↗出版商官网 ·- 作者资格 Copyright and authorship
Copyright on all accepted manuscripts will be held by the Association of Gynecological Oncologists of India (AGOI). It is mandatory that the Copyright/Authorship Form is signed by all the authors, expressly transferring copyright to AGOI in the event the manuscript is accepted for publication. This form must be submitted along with the manuscript on the Editorial Manager. The form can be downloade…
原文 ↗出版商官网 ·- 利益冲突 Disclosures and declarations
All authors are requested to include information regarding sources of funding, financial or non-financial interests, study-specific approval by the appropriate ethics committee for research involving humans and/or animals, informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals (as appropriate). The decision whether such …
原文 ↗出版商官网 ·- 数据可用性
Data transparency policy 模型摘要
All authors are requested to make sure that all data and materials as well as software application or custom code support their published claims and comply with field standards.
原文 ↗出版商官网 ·- 出版伦理 Compliance with Ethical Standards
Retrospective ethics approval policy 模型摘要
To ensure objectivity and transparency in research and to ensure that accepted principles of ethical and professional conduct have been followed, authors should include information regarding sources of funding, potential conflicts of interest (financial or non-financial), informed consent if the research involved human participants, and a statement on welfare of animals if the research involved an…
原文 ↗出版商官网 ·- 许可与版权 Copyright and authorship
Copyright held by AGOI 模型摘要
Copyright on all accepted manuscripts will be held by the Association of Gynecological Oncologists of India (AGOI). It is mandatory that the Copyright/Authorship Form is signed by all the authors, expressly transferring copyright to AGOI in the event the manuscript is accepted for publication. This form must be submitted along with the manuscript on the Editorial Manager. The form can be downloade…
原文 ↗出版商官网 ·- 开放获取 Open access publishing
Open Choice open access with Creative Commons license 模型摘要
To find out more about publishing your work Open Access in Indian Journal of Gynecologic Oncology, including information on fees, funding and licences, visit our Open access publishing page. Back to top
原文 ↗出版商官网 ·- 同行评审 Double-blind peer review
Double-blind peer review 模型摘要
This journal follows a double-blind reviewing procedure. This means that the author will remain anonymous to the reviewers throughout peer review. It is the responsibility of the author to anonymize the manuscript and any associated materials. Author names, affiliations and any other potentially identifying information should be removed from the manuscript text and any accompanying files (such as …
原文 ↗出版商官网 ·- 试验注册 / 报告规范 Clinical Trial Registration
The World Health Organization (WHO) definition of a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to ass…
原文 ↗出版商官网 ·
摘录来自期刊官网页面，仅保留原文片段；“模型摘要”由 Workers AI 生成并经原文校验，以官网为准。
基本信息
出版信息与官方入口
- 出版商
- Springer Nature
- ISSN
- 2363-8397
- 电子版 ISSN
- 2363-8400
- 学会 / 主办单位
- Association of Gynecological Oncologists of India
- 官方链接
- 期刊主页 ↗OpenAlex
- 投稿系统 ↗出版商官网
- 专刊 / 特刊征稿 ↗出版商官网
常见问题
关于 Indian Journal of Gynecologic Oncology 的常见问题
Indian Journal of Gynecologic Oncology 是中科院几区期刊？
2025 年升级版分区表中，Indian Journal of Gynecologic Oncology 为医学 4区，小类 妇产科学 4 区。2026 年新锐版分区表中为医学 4区。不同版本与大小类分区不能混用。
Indian Journal of Gynecologic Oncology 的影响因子是多少？
期刊官网公布的影响因子为 0.3（2025 年度），属期刊自述数据，LetPub 暂无该刊的影响因子记录，CiteScore 为 0.7，h-index 为 13。
Indian Journal of Gynecologic Oncology 的审稿周期多长？
按 2024年10月至2026年10月（近 24 个月）89 篇已发表文章登记的日期，投稿到接收的中位数为 119 天（四分位 86–166 天）。文章统计只含被录用的稿件，出版商数据口径以官网为准，社区反馈来自投稿者样本，均不代表期刊承诺。
Indian Journal of Gynecologic Oncology 的投稿格式要求是什么？
据期刊作者指南：摘要：150–250 词；关键词：≥ 4 个；正文篇幅：≤ 3,000 词；参考文献格式：顺序编码制（按引用顺序编号）；推荐审稿人：可选。以上由模型从作者指南提取并逐项与原文核对，投稿前请以官网最新版本为准。
Indian Journal of Gynecologic Oncology 的编委会里有中国学者吗？
期刊官网编委会页面上标注了国家的 47 位编委中，没有中国大陆学者；人数最多的国家是 印度（38 位）、美国（6 位）、英国（2 位）。统计按编委会页面列出的机构国家计，仅供参考。
Indian Journal of Gynecologic Oncology 被哪些数据库收录？
据 LetPub 与 DOAJ 记录，Indian Journal of Gynecologic Oncology 被 ESCI、Scopus 收录。期刊官网自述还被 Embase 收录，该清单未与各数据库逐一核对。
Indian Journal of Gynecologic Oncology 是开放获取期刊吗？版面费多少？
Indian Journal of Gynecologic Oncology 为订阅期刊。APC 约 2,990 美元。
来源与更新
本页事实来自 LetPub、OpenAlex、出版商官网；每个数字旁标注来源与观测日期，冲突数据保留各来源原值。LetPub 原始详情页：查看 ↗（2026-08-26 归档）。最近更新：。